Turnstone Biologics Corp. (TSBX)
NASDAQ: TSBX · Real-Time Price · USD
0.4100
-0.0010 (-0.24%)
Mar 31, 2025, 10:46 AM EDT - Market open
Turnstone Biologics Stock Forecast
TSBX's stock price has decreased by -85.48% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Turnstone Biologics stock have an average target of 4.75, with a low estimate of 0.50 and a high estimate of 10. The average target predicts an increase of 1,058.54% from the current stock price of 0.41.
Analyst Consensus: Buy
* Price targets were last updated on Oct 14, 2024.
Analyst Ratings
The average analyst rating for Turnstone Biologics stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $10 → $0.5 | Strong Buy → Hold | Downgrades | $10 → $0.5 | +21.95% | Oct 14, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $12 → $10 | Strong Buy | Maintains | $12 → $10 | +2,339.02% | Aug 19, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $20 → $3.75 | Buy | Maintains | $20 → $3.75 | +814.63% | Aug 19, 2024 |
| B of A Securities | B of A Securities | Strong Buy Initiates $18 | Strong Buy | Initiates | $18 | +4,290.24% | Aug 15, 2023 |
| Piper Sandler | Piper Sandler | Buy Initiates $20 | Buy | Initiates | $20 | +4,778.05% | Aug 15, 2023 |
Financial Forecast
Revenue This Year
n/a
from 19.31M
Revenue Next Year
n/a
EPS This Year
-3.35
from -4.78
EPS Next Year
-0.69
from -3.35
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | n/a | n/a | n/a | |||
| Avg | n/a | n/a | n/a | |||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.37 | -0.27 | -0.35 |
| Avg | -3.35 | -0.69 | -0.34 |
| Low | -3.29 | -1.07 | -0.32 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.